LAG3 and gastric cancer: Consistent with findings from our study, Park et al. reported that high immune checkpoint receptor expression (including PD-1, LAG3 and TIM3) was mainly expressed in CD8 + T-cells and showed improved survival in stage II and III gastric cancer patients [34].